Renal care company gets $20 million for development
This article was originally published in Clinica
Executive Summary
In-Line Diagnostics, a small privately-funded renal care company that is developing non-invasive technology to measure whole blood constituents during dialysis, has raised private equity funding of $20 million. The money will be used to take the technology into new areas.